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Structural and functional analysis of mRNA export
regulation by the nuclear pore complex
Daniel H. Lin1, Ana R. Correia1, Sarah W. Cai1, Ferdinand M. Huber1, Claudia A. Jette1 & André Hoelz 1
The nuclear pore complex (NPC) controls the passage of macromolecules between the
nucleus and cytoplasm, but how the NPC directly participates in macromolecular transport
remains poorly understood. In the ﬁnal step of mRNA export, the DEAD-box helicase DDX19
is activated by the nucleoporins Gle1, Nup214, and Nup42 to remove Nxf1•Nxt1 from mRNAs.
Here, we report crystal structures of Gle1•Nup42 from three organisms that reveal an evo-
lutionarily conserved binding mode. Biochemical reconstitution of the DDX19 ATPase cycle
establishes that human DDX19 activation does not require IP6, unlike its fungal homologs,
and that Gle1 stability affects DDX19 activation. Mutations linked to motor neuron diseases
cause decreased Gle1 thermostability, implicating nucleoporin misfolding as a disease
determinant. Crystal structures of human Gle1•Nup42•DDX19 reveal the structural rear-
rangements in DDX19 from an auto-inhibited to an RNA-binding competent state. Together,
our results provide the foundation for further mechanistic analyses of mRNA export in
humans.
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The ﬂow of genetic information requires newly transcribedand processed mRNAs to be exported from the nucleus tothe cytoplasm through nuclear pore complexes (NPCs).
NPCs are massive macromolecular machines perforating the
nuclear envelope, each composed of ~1000 protein subunits
(collectively termed nucleoporins) totaling to a molecular mass of
~120MDa in humans1. By fusing the inner and outer nuclear
membranes, NPCs create pores through the nuclear envelope and
simultaneously generate a passive diffusion barrier composed of
disordered protein sequences enriched in phenylalanine-glycine
(FG) repeats. Each NPC is composed of a ~60MDa symmetric
core that is decorated by different proteins on its nuclear and
cytoplasmic faces, which are referred to as the nuclear basket and
cytoplasmic ﬁlament nucleoporins, respectively (Fig. 1a).
The architecture of the symmetric core of the human NPC has
recently been elucidated2,3. In humans, the symmetric core is
composed of an inner ring that resides in the plane of the
membrane and two concentric outer rings that reside above the
inner and outer nuclear membranes. The outer rings, which serve
as the attachment sites for the nuclear basket and cytoplasmic
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Fig. 1 Gle1 is anchored to the nuclear pore complex through a competitive interaction with Nup98. a Cartoon schematic of the human nuclear pore
complex (NPC). The circle highlights the region of the NPC to which the proteins used in this study localize. b Domain schematics for nucleoporins used in
this study. Protein names and boundaries correspond to the human proteins. c Size exclusion chromatography (SEC) analysis of the interaction between
Nup155CTD, SUMO-Gle1N, and Nup98ΔFG. Puriﬁed Nup155CTD•SUMO-Gle1N complex was mixed with the indicated amounts of Nup98ΔFG and loaded
onto a Superdex 200 10/300 GL column. The gray bar indicates the fractions visualized with Coomassie-stained SDS-PAGE gels. d Left: table summarizing
SEC analysis of Nup155CTD variants for Nup98ΔFG and SUMO-Gle1N binding. See also Supplementary Fig. 2. Right: the homologous positions were colored
on the C. thermophilum Nup170•Nup145N structure (PDB ID 5HB0), indicating that the same binding surface is recognized by Nup98ΔFG and SUMO-Gle1N
[2]. e Summary of the effect of Gle1N alanine substitution variants on Nup155CTD binding. Colored dots above the sequence of Gle1N indicate the effect of
the substitution, green for wild-type levels of complex formation, orange for reduced binding, or red for complete disruption. See also Supplementary Fig. 2.
f Identiﬁcation of the Gle1 binding site suggests that the unassigned cytoplasmic density adjacent to bridging Nup155 molecules could contain Gle1 and its
binding partners. Left: surface representation of the composite structure of the NPC2. Right: zoomed view of unassigned cytoplasmic density, with
Nup155 shown in orange, Gle1N binding site colored in green, and coat nucleoporin complexes shown in yellow
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ﬁlaments, are structurally connected to the inner ring via bridging
Nup155 molecules. In addition to large interaction interfaces
between scaffold proteins, the assembly of the symmetric core
requires interactions mediated by ﬂexible linker sequences
residing in Nup98, Nup53, and Nup932,4,5. In contrast, the
molecular organization of the cytoplasmic ﬁlaments and nuclear
basket remains poorly understood.
Preparation of mRNAs for nuclear export is a highly coordi-
nated process that begins co-transcriptionally and results in the
addition and removal of mRNA-binding proteins during tran-
scription and nuclear processing until an export-competent
messenger ribonucleoprotein particle (mRNP) is formed6.
Although some mRNAs may be exported through specialized
pathways, the bulk of mRNA export is mediated by the evolu-
tionarily conserved, heterodimeric transport factor complex
Nxf1•Nxt17. Nxf1•Nxt1 binds mRNAs without strong sequence
preference and can shuttle mRNAs through the NPC diffusion
barrier by binding to FG repeats. At the cytoplasmic face of the
NPC, Nxf1•Nxt1-bound mRNPs encounter the cytoplasmic ﬁla-
ment nucleoporins Gle1, Nup42, and Nup214, which speciﬁcally
activate the DEAD-box helicase DDX19 to remove Nxf1•Nxt1
from the mRNP8. This spatial regulation of activity prevents re-
import of mRNPs into the nucleus, and thus ensures the direc-
tionality of mRNA export.
DDX19 is a member of the DEAD-box helicase family, which
are RNA-dependent ATPases composed of two RecA domains
(referred to as DDX19NTD and DDX19CTD throughout the text)
(Fig. 1b). Many insights into the regulation of DDX19 come from
studies of the fungal homolog, Dbp5. Genetic, biochemical, and
structural studies of the yeast proteins have revealed that the
interaction between Gle1 and Dbp5 occurs via their C-terminal
domains (CTDs) and is bridged by the small molecule inositol
hexaphosphate (IP6)9–12. In yeast, Gle1, IP6, and RNA cooperate
to stimulate the ATPase activity of Dbp5, although the precise
mechanism remains debated10,13. The functional roles of Nup42
and Nup214 are also unclear. The interaction between Nup214
and DDX19 is required for steady-state localization of DDX19 to
the NPC, but Nup214 binding also inhibits DDX19 activity14–17.
Nup42 binds to Gle1, but its contributions to DDX19 activity
are unknown18,19. DDX19 and Gle1 have been implicated in
other cellular processes including transcription regulation,
DNA damage response, translation initiation, and RNA
processing20–25.
Impairment of nucleocytoplasmic transport through the NPC
has been linked to both Huntington’s disease and amyotrophic
lateral sclerosis (ALS)26–30. Nucleocytoplasmic transport factors
and nucleoporins, including Gle1, are genetic modiﬁers of disease
in model systems and are mislocalized in both model organism
and patient samples26–29,31,32. Speciﬁc mutations of Gle1 are
associated with lethal contracture congenital syndrome 1
(LCCS1), lethal arthrogryposis with anterior horn cell disease
(LAAHD), and ALS33,34. However, deciphering how defects in
nucleocytoplasmic transport can lead to disease will require an
improved understanding of the regulation of transport through
the NPC.
To gain further mechanistic insight into the role of nucleo-
porins in mRNA export, we characterized the molecular archi-
tecture of the cytoplasmic ﬁlament nucleoporins involved in
regulating DDX19 activity. We mapped the Gle1-binding site on
Nup155 and found that it overlaps with the Nup98 binding site,
thereby acquiring a spatial restraint for Gle1 localization in the
NPC. Crystal structures of the Gle1•Nup42 complex from Sac-
charomyces cerevisiae, Chaetomium thermophilum, and Homo
sapiens revealed the evolutionarily conserved structural basis of
their interaction. Nup42 is critical for the thermostability of
human Gle1, enabling Gle1 puriﬁcation from a recombinant
source and characterization of its role in human DDX19 activa-
tion, which unlike the yeast system does not require IP6 binding.
Crystal structures of the human Gle1•Nup42•DDX19 complex
bound to ADP and AMP-PNP•Mg2+ uncovered the adaptations
that facilitate IP6-independent activation in humans and the
speciﬁc Gle1-induced conformational changes that release
DDX19 from an auto-inhibited state. Lastly, Gle1 mutations that
are associated with motor neuron diseases possess severe ther-
mostability defects, suggesting that nucleoporin misfolding con-
tributes to disease.
Results
Gle1 and Nup98 recognize overlapping surfaces on Nup155. To
gain a better understanding of the molecular architecture of the
nucleoporins that regulate mRNA export, we set out to recon-
stitute the interactions with puriﬁed, recombinant proteins. We
use the names of the human proteins unless otherwise speciﬁed.
In humans, there are two splice variants of the Gle1 transcript,
Gle1A and Gle1B, which encode proteins that are primarily
localized in the cytoplasm or at the cytoplasmic face of the NPC,
respectively35. We focused on the NPC-localized Gle1B, referred
to as Gle1 throughout the text. Human Gle1 can be divided into
three structural domains: an unstructured N-terminal region
(Gle1N, residues 1−123), a coiled-coil region (Gle1CC, residues
124–355), and a highly conserved CTD (Gle1CTD, residues
382–698) (Fig. 1b). Gle1CTD is the domain that binds and sti-
mulates DDX19, but previous studies have identiﬁed features in
all three regions that are important for NPC localization19,36,37.
We began our analysis by focusing on the interaction between
Gle1 and the adaptor nucleoporin Nup155 (Nup170 in fungi).
Although the ﬁrst 28 residues of Gle1 were previously shown to
be sufﬁcient for an interaction, we used a SUMO-fusion construct
that also included several charged residues at the C-terminus to
enhance protein solubility (SUMO-Gle1N, residues 2–33)37. The
Nup155 CTD (Nup155CTD, residues 870–1391) and SUMO-
Gle1N formed a stoichiometric complex in size exclusion
chromatography (SEC) experiments (Fig. 1c; Supplementary
Fig. 1a). Nup155CTD also contains a binding site for Nup98,
which is both a component of the symmetric core of the NPC and
of the cytoplasmic ﬁlaments2,4. Stoichiometric complex formation
also occurred between Nup155CTD and a construct of Nup98
lacking the FG repeat region (Nup98ΔFG, residues 498–880)
(Supplementary Fig. 1b). However, when we attempted to
reconstitute a heterotrimeric complex by adding Nup98ΔFG to
Nup155CTD•SUMO-Gle1N, complex formation between
Nup155CTD and Nup98ΔFG coincided with displacement of
SUMO-Gle1N, suggesting that the interactions were mutually
exclusive (Fig. 1c; Supplementary Fig. 1a). Similarly, addition of
SUMO-Gle1N to Nup155CTD•Nup98ΔFG failed to yield a
heterotrimeric complex (Supplementary Fig. 1b). This effect was
speciﬁc to Nup98, as addition of the N-terminal domain of
Nup214 (Nup214NTD) to Nup155CTD•SUMO-Gle1N did not
displace SUMO-Gle1N (Supplementary Fig. 1c). In GST-pull-
down experiments, Gle1N efﬁciently outcompeted Nup98ΔFG for
Nup155CTD binding, whereas conversely, Nup98ΔFG could not
outcompete Gle1N, suggesting that Gle1N binds with greater
afﬁnity to Nup155CTD than Nup98ΔFG (Supplementary Fig. 1d).
We next expanded upon previous mutational and structural
analyses using the C. thermophilum proteins2. Amino acid
substitutions at positions homologous to those that abolished
binding for the C. thermophilum proteins also disrupted binding
between human Nup155CTD and Nup98ΔFG, demonstrating that
the mechanism of interaction between these two nucleoporins is
evolutionarily conserved (Fig. 1d; Supplementary Fig. 2a). More-
over, most residues that were critical for Nup98ΔFG binding were
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also important for Gle1N binding, except for two residues that
each affected only one nucleoporin, indicating that Gle1N and
Nup98ΔFG recognize overlapping surfaces on Nup155CTD (Fig. 1d;
Supplementary Fig. 2b). Hydrophobic residues in Gle1N were
critical for Nup155CTD binding, consistent with utilization of the
same hydrophobic pockets as Nup98ΔFG (Fig. 1e; Supplementary
Fig. 2c).
In summary, we found that Gle1N and Nup98ΔFG recognize
overlapping surfaces on Nup155CTD. Nup155 molecules bridge
the inner ring to the cytoplasmic and nuclear outer coat
nucleoporin complex (CNC) double rings (Fig. 1a)2,3. Because
Gle1N efﬁciently outcompetes Nup98ΔFG for binding, Gle1 would
likely prevail for binding to Nup155 molecules exposed to the
cytoplasmic face. Indeed, in the cytoplasmic outer ring, but not
the nuclear outer ring, there is a volume of unaccounted density
directly adjacent to the Nup155CTD surface that binds Gle1N
(Fig. 1f). Our analysis suggests this density contains the
remainder of the Gle1 molecule and its binding partners.
Identiﬁcation of a minimal Nup42 Gle1-binding fragment. We
next focused on the interaction between Gle1CTD and Nup42.
Previous studies have shown that the C-terminal, non-FG repeat
region of Nup42 binds Gle1CTD19,38. To identify the minimally
sufﬁcient fragment of Nup42 that recognizes Gle1, we monitored
the localization of Gle1-GFP and mCherry-HA-tagged Nup42
variants in S. cerevisiae39. Nup42 truncations that contained
residues 397–430 displayed nuclear rim staining consistent with
localization to the NPC, whereas an Nup42 variant containing
only residues 410–430 did not (Fig. 2a). From these results, we
concluded that the Nup42 Gle1-binding motif (Nup42GBM) is
located within residues 397–430 (See Supplementary Note 1).
When we recombinantly puriﬁed the minimal S. cerevisiae
Gle1CTD•Nup42GBM complex, we noticed that the puriﬁed
complex was more stable than apo Gle1CTD, which typically
requires the addition of IP6 in puriﬁcation buffers for stability10.
This observation led us to test the effect of IP6 and Nup42GBM on
the stability of Gle1CTD using two different assays: differential
scanning ﬂuorimetry and a protein solubility assay. In both
experiments, IP6 potently improved Gle1CTD stability, with
saturating amounts of IP6 shifting the melting temperature
(Tm) from 22 to 37 °C (Fig. 2b; Supplementary Fig. 4a).
Nup42GBM had an even more dramatic effect, increasing the
Tm from 22 to 46 °C, and the presence of both IP6 and Nup42GBM
shifted the Tm of Gle1CTD to 53 °C (Fig. 2b; Supplementary
Fig. 4a).
The difﬁculty of purifying human Gle1CTD has previously
prevented a detailed biochemical analysis of the human proteins,
but the dramatic effect of yeast Nup42GBM on Gle1CTD stability
led us to test whether human Nup42GBM has the same effect on
human Gle1CTD. Co-puriﬁcation of a homologous human
Gle1CTD•Nup42GBM complex (containing Gle1 residues 382
−698 and Nup42 residues 379−423) resulted in dramatic
improvements in the stability of Gle1CTD and the yields increased
from ~0.5 to ~50 mg/100 l of bacterial culture. In thermostability
experiments, the Tm of human Gle1CTD increased from 37 to 50 °
C in the presence of Nup42GBM (Fig. 2c; Supplementary Fig. 4b).
However, in contrast to the yeast proteins, IP6 had almost no
effect on thermostability for human Gle1CTD (Fig. 2c; Supple-
mentary Fig. 4b). In summary, we identiﬁed an evolutionarily
conserved C-terminal fragment of Nup42 that binds Gle1 and has
a profound effect on Gle1 stability in both yeast and humans.
Evolutionary conservation of the Gle1−Nup42 interaction. To
understand the molecular basis for the interaction between
Gle1CTD and Nup42GBM and the resulting stabilization of
Gle1CTD, we determined the crystal structure of S. cerevisiae
Gle1CTD•Nup42GBM at 1.75 Å resolution (Fig. 2d; Supplementary
Table 1). Nup42GBM folds into a compact domain with a
hydrophobic core that buries a solvent-exposed hydrophobic
surface on Gle1CTD, yielding an interaction interface area of
~835 Å2 (Fig. 2d; Supplementary Fig. 5a; See Supplementary
Note 2 for details). Consistent with the extensive interaction
surface, the interaction between Gle1CTD and Nup42GBM was
robust against several individual alanine substitutions in SEC
experiments (Supplementary Fig. 6a). Instead, highly disruptive
substitutions that introduced negative charge into the hydro-
phobic core (F414D or F409D/F414D) were required to com-
pletely disrupt the interaction between Gle1CTD and Nup42GBM
(Supplementary Fig. 6b). In agreement with these results, Nup42
variants containing the F414D or F409D/F414D substitutions
were unable to rescue Nup42 deletion in S. cerevisiae (Supple-
mentary Fig. 3). In contrast, the F409D substitution in the Nup42
hydrophobic core did not ablate binding, but did alter the elution
proﬁle, suggesting a conformational difference in the complex
(Supplementary Fig. 6b). Accordingly, an Nup42 variant har-
boring the F409D substitution only had a mild effect on growth at
37 °C (Supplementary Fig. 3a).
To evaluate whether the mode of interaction observed for
S. cerevisiae Gle1CTD•Nup42GBM was conserved in other
eukaryotes, we determined the crystal structures of human
Gle1CTD•Nup42GBM at 2.8 Å resolution and of C. thermophilum
Gle1CTD•Nup42GBM in the presence and absence of IP6 at 2.17
and 2.65 Å resolution, respectively (Fig. 2e, f; Supplementary
Fig. 7a; Supplementary Tables 1 and 2). The overall structure of
Gle1CTD is conserved between fungi and humans, with minor
differences resulting from small insertions or different loop sizes
(Fig. 2g; Supplementary Fig. 8 and Supplementary Movie 1). Both
human and C. thermophilum Nup42GBM adopt the same fold as
S. cerevisiae Nup42GBM and recognize the same surface on
Gle1CTD, with the critical hydrophobic residues nearly universally
conserved (Fig. 2i, j; Supplementary Figs. 8–11; See Supplemen-
tary Note 2 for details). Many of the critical interaction interfaces
in the NPC likely possess a similar degree of structural
conservation. Burial of the exposed hydrophobic residues and
the thermodynamic favorability of Nup42GBM binding and
folding explain the large effect Nup42GBM has on Gle1CTD
stability. Nup42GBM binding may also help prevent Gle1CTD
from sampling partially unfolded states that could lead to
aggregation. The remainder of Nup42 is comprised primarily of
FG repeats. In yeast, deletion of these FG repeats was detrimental
when combined with the deletion of other FG repeats in the
cytoplasmic ﬁlaments40. Thus, in addition to ensuring the
stability of Gle1CTD, Nup42GBM also has a role in anchoring
FG repeats proximal to Gle1 in the NPC.
The IP6 binding pocket is not conserved in metazoan Gle1. In
yeast, activation of Dbp5, the fungal homolog of DDX19, requires
the small molecule IP6, which binds to a highly positively charged
pocket in Gle1CTD adjacent to the Dbp5 binding surface and
bridges the two proteins9–11. Our Gle1CTD•Nup42GBM structure
reveals that Nup42GBM interacts with Gle1CTD at a surface that is
distinct and well separated from the IP6 binding pocket and the
Dbp5 interface (Supplementary Fig. 5a)10. Thus, in order for
Nup42GBM binding to affect Dbp5 activation, it would have to do
so through an allosteric mechanism. However, there were mini-
mal conformational differences in Gle1CTD between our
Gle1CTD•Nup42GBM structure and the previously reported
structure of Gle1CTD•IP6•Dbp5 (Supplementary Fig. 7b)10.
Similarly, C. thermophilum Gle1CTD•Nup42GBM undergoes
minimal conformational changes upon IP6 binding, which are
mostly limited to a loop directly adjacent to the IP6 pocket. IP6
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binds to C. thermophilum Gle1CTD and to S. cerevisiae Gle1CTD
in a similar orientation, suggesting that IP6 could function
similarly in C. thermophilum as in S. cerevisiae (Fig. 3a, b, d, e;
Supplementary Fig. 7d; See Supplementary Note 3). However,
because there are no apo Gle1CTD structures available, we could
not exclude the possibility that Nup42GBM binding caused
Gle1CTD to adopt the same conformation as the one observed
upon IP6 and Dbp5 binding.
b
c
d
g
a
scGle1CTD
+ IP6
scGle1CTD•Nup42GBM
+ IP6
hsGle1CTD
+ IP6
hsGle1CTD•Nup42GBM
+ IP6
Gle1
Nup42
C N
C
N
Gle1
Nup42
C
N
180°
scGle1CTD•Nup42GBM hsGle1CTD•Nup42GBM ctGle1CTD•Nup42GBM
scGle1CTD•Nup42GBM hsGle1CTD•Nup42GBM ctGle1CTD•Nup42GBMSuperposition
e
Gle1
N
C
Nup42 C
N
DIC
Nup42-
mCherry-HA
Gle1-
GFP DIC
Nup42-
mCherry-HA
Gle1-
GFP
30 °C 42 °C, 3 h
f
Gle1
N
CNup42
Extended
N-terminus
N
C
n
u
p4
2Δ
/g
le
1-
G
FP
1 430397
FG mCherry HA
Nup42FL
Nup42364-430
Nup42397-430
Nup42410-430
Nup421-394
h
F409
P424
P425
P423
Y488
W451
L495
Q491L401 L428
D421
V419
R456
I408
K494
F414
P420
N459
A455
L498
P426
i
P417
P416
P415
I411
Y637
Q640
I385
W602
M644
L413
N610
L647
P412
K643
F401
F406
j
F539
Y521 V520
P548
P547
P544
Y484
W447
F533
W530
N455A451
M543
A491
10080604020
Temperature (°C)
10080604020
Temperature (°C)
50
40
30
20
10
0
R
F
U
 (
×
10
3 )
50
40
30
20
10
0
R
F
U
 (
×
10
3 )
37
50
38
51
22
37 46
53
Fig. 2 A conserved mechanism for Gle1•Nup42 complex formation. a In vivo localization analysis of Gle1-GFP and Nup42-mCherry-HA variants in nup42Δ/
gle1-GFP S. cerevisiae cells. Scale bar is 5 μm. Schematics on the right indicate the Nup42 fragments that were included in the construct, with omitted
fragments indicated by replacement of the domain with a solid line. Residue numbers indicate the fragment included in each construct. See also
Supplementary Fig. 3. b, c Differential scanning ﬂuorimetry analysis of b S. cerevisiae or c H. sapiens Gle1CTD thermostability in the presence and absence of
Nup42GBM and IP6. Exposure of hydrophobic residues was monitored by an increase in relative ﬂuorescence units (RFUs). Curves represent the average of
three experiments. See also Supplementary Fig. 4. d−f Crystal structures of d S. cerevisiae, e H. sapiens, or f C. thermophilum Gle1CTD•Nup42GBM. See also
Supplementary Figs. 5 and 8–11. g Superposition of the structures of S. cerevisiae, H. sapiens, and C. thermophilum Gle1CTD•Nup42GBM, with same coloring as
in d−f. See also Supplementary Movie 1. h−j Zoom views of h S. cerevisiae, i H. sapiens, or j C. thermophilum Gle1CTD•Nup42GBM interactions with residues
mediating the interaction labeled
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In contrast to the IP6 binding pockets of S. cerevisiae and C.
thermophilum Gle1CTD, the same location on the surface of the
H. sapiens molecule was signiﬁcantly altered, resulting in a
substantial reduction in positive electrostatic potential (Fig. 3a
−f). This was the consequence of several positively charged
residues that are essentially invariant in fungi (S. cerevisiae
residues K264, K286, K333, and R374; C. thermophilum residues
K225, R249, K327, and K374), but are not conserved in humans
(V401, Q423, E482, and H523) (Fig. 3a−c). This trend held for all
the metazoan sequences inspected, indicating that the altered
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electrostatic potential in this pocket may be a general feature of
metazoan Gle1 (Supplementary Fig. 12a). Although there are two
positions in human Gle1 that contained lysine residues not
present in the fungal proteins, sequence conservation analysis also
indicated that the positively charged residues in Dbp5 that bind
IP6 were not conserved in metazoans (Supplementary Fig. 12b).
Combined, these structural observations raised the question of
what roles Nup42 and IP6 had on the activation of human
DDX19.
The roles of IP6 and Nup42 in DDX19/Dbp5 stimulation. To
assess the role of IP6 in DDX19 activation, we ﬁrst tested whether
complex formation between human DDX19 and Gle1 was
dependent on IP6 in SEC experiments. Consistent with previous
reports, S. cerevisiae Dbp5 and Gle1CTD•Nup42GBM only formed
a complex in the presence of IP6 (Fig. 3g)10. The interaction
between C. thermophilum Gle1CTD•Nup42GBM and Dbp5 also
required IP6, consistent with the evolutionary conservation of the
IP6 binding residues among fungi (Fig. 3h,; Supplementary
Fig. 12a). In contrast, complex formation of the human proteins
did not require IP6, and the presence of IP6 instead partially
reduced complex formation (Fig. 3i).
To directly test the effect of IP6 and Nup42 on Dbp5 and
DDX19 activity, we measured steady-state ATP hydrolysis rates
with an NADH-coupled reaction using conditions identical to
those previously reported41. Due to concerns that observed
differences in activity were due to the stabilizing effects of IP6 and
Nup42 on Gle1 rather than direct roles in Dbp5/DDX19
activation, we measured ATP hydrolysis rates at multiple
temperatures to decouple the effects due to stabilization from
bona ﬁde stimulatory roles. Because human DDX19 was
intrinsically less active than S. cerevisiae Dbp5, we used ﬁvefold
higher concentrations of human DDX19, Gle1CTD, Nup42GBM,
and IP6 to ensure accurate measurements of ATPase activity.
Furthermore, because Dbp5 and DDX19 are slow ATPases, we
developed extensive protein puriﬁcation protocols to ensure all of
the measured activity was directly attributable to Dbp5 or DDX19
(Supplementary Fig. 13a, b).
In the yeast system, and across a range of RNA concentrations,
the addition of Nup42GBM to Gle1CTD increased Dbp5 activity at
37 °C, but this stimulatory effect was greatly diminished at 30 °C,
a temperature below the Tm of Gle1CTD•IP6, which is consistent
with thermostability having a detectable effect in our assays
(Fig. 4a, c; Supplementary Fig. 13c). Altogether, these data
indicate that Nup42GBM does not have a direct role in
Dbp5 stimulation in the yeast system, but rather functions
primarily to ensure Gle1 stability. In the yeast system, IP6 was
required for full stimulation of Dbp5 at all temperatures tested,
indicating that in addition to its ability to stabilize yeast Gle1CTD,
IP6 also has a direct role in Dbp5 stimulation (Fig. 4a;
Supplementary Fig. 13c, d). These results are in agreement with
the observation that stable association of Gle1CTD and Dbp5
requires IP6 binding. In contrast, neither Nup42GBM nor IP6 were
stimulatory in the human system at either temperature we tested
(Fig. 4b, d; Supplementary Fig. 13e).
Because differences in the IP6 binding pocket in human Gle1
and DDX19 could have weakened the afﬁnity for IP6 rather than
completely abolishing binding, we tested whether higher
concentrations of IP6 would stimulate DDX19. IP6 stimulated
Dbp5 activity in a dose-dependent manner that saturated at 1 μM
(twice the Dbp5 concentration), but had no effect on human
DDX19 activity up to concentrations of 100 μM, which is an
upper estimate for the total (bound and free) IP6 concentration in
human cells (Fig. 4e)42. Additionally, IP6 bound tightly to S.
cerevisiae Gle1CTD•Nup42GBM in isothermal titration calorimetry
experiments (ITC) with a dissociation constant (Kd) of ~3 nM.
However, no binding of IP6 to human Gle1CTD•Nup42GBM was
detected up to concentrations of 200 μM (Supplementary Fig. 14).
Taken together, our results indicate that IP6 binding is conserved
in fungi but not in humans. Moreover, sequence analysis of other
metazoan Gle1 and DDX19 sequences suggests that IP6 binding
may not be a feature of metazoan DDX19 activation in general, as
IP6-binding residues are not present in a diverse array of
metazoan sequences (Supplementary Fig. 12a). These results do
not exclude the possibility that another small molecule may serve
a similar function in humans as IP6 does in fungi. However,
unlike their fungal homologs, the human proteins alone are
sufﬁcient for complex formation.
Structural basis for IP6-independent human DDX19 activa-
tion. To understand the structural basis for IP6-independent
DDX19 activation, we determined crystal structures of human
Gle1CTD•Nup42GBM in complex with DDX19 in the presence of
ADP or AMP-PNP•Mg2+ at 3.6 and 3.4 Å resolution, respectively
(Fig. 5a, d; Supplementary Table 3). Previous structural studies
have revealed that DDX19 possesses an auto-inhibitory helix N-
terminal to DDX19NTD (residues 54–67) that can bind between
DDX19NTD and DDX19CTD, preventing RNA binding or for-
mation of a catalytically competent active site43. This helix
appears to be conserved among metazoan DDX19 sequences, but
is absent in their fungal Dbp5 homologs (Supplementary Fig. 15).
Therefore, we used a construct of DDX19 that contained the N-
terminal auto-inhibitory helix but did not contain the ﬂexible N-
terminal extension (DDX19ΔN53, residues 54–479). In addition,
we determined the crystal structure of apo DDX19ΔN53(AMP-
PNP•Mg2+) at 2.2 Å resolution (Supplementary Fig. 16a; Sup-
plementary Table 3).
The heterotrimeric Gle1CTD•Nup42GBM•DDX19ΔN53 complex
exhibited similar conformations in the presence of ADP or AMP-
PNP•Mg2+, with the auto-inhibitory helix still bound between
DDX19NTD and DDX19CTD (Fig. 5a, d). The surprising
observation that AMP-PNP-bound DDX19 could also adopt the
auto-inhibited conformation was conﬁrmed by the structure of
apo DDX19ΔN53(AMP-PNP•Mg2+), which adopted an identical
conformation as apo DDX19ΔN53(ADP) (Supplementary
Fig. 16a)43. The inhibited state does not differ structurally in
the presence of ADP or ATP, as the nucleotide-binding pocket
readily accommodates the additional phosphate and Mg2+ ion,
with minor changes in the sidechain conformations of K64 from
Fig. 3 Human Gle1CTD binding to DDX19 is IP6 independent. a−c Zoom view of the IP6 binding pocket of a S. cerevisiae, b C. thermophilum, or c H. sapiens
Gle1CTD. Residues that are conserved in fungi but not metazoans are highlighted in red. See also Supplementary Figs. 7 and 12. d−f Surface electrostatic
potential analysis of IP6 binding pockets for d S. cerevisiae, e C. thermophilum, or f H. sapiens Gle1. The same view as a−c is shown in surface representation
colored by electrostatic potential, from red (−10 kBT/e) to white (0 kBT/e) to blue (+10 kBT/e), revealing a dramatically reduced electrostatic potential for
human Gle1CTD. See also Supplementary Figs. 5, 10, and 11. g−i SEC analysis of the interaction between Dbp5/DDX19 and Gle1CTD•Nup42GBM for g S.
cerevisiae, h C. thermophilum, or i H. sapiens, in the presence or absence of IP6. The elution proﬁles for Dbp5/DDX19 are shown in purple,
Gle1CTD•Nup42GBM and IP6 are shown in gray, Gle1CTD•Nup42GBM without IP6 are shown in orange, Dbp5/DDX19 with Gle1CTD•Nup42GBM and IP6 are
shown in light blue, and Dbp5/DDX19 with Gle1CTD•Nup42GBM without IP6 are shown in black. Fungal Gle1CTD•Nup42GBM interacts strongly with the
Superdex matrix in the absence of IP6. The gray horizontal bar indicates fractions visualized with Coomassie-stained SDS-PAGE gels shown below
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the auto-inhibitory helix and E243 in the nucleotide binding
pocket (Supplementary Fig. 16b).
The Gle1CTD−DDX19CTD interface involves 40 Gle1 and 35
DDX19 residues to generate an interaction interface area of
almost 1300 Å2 (Supplementary Fig. 10). As in the yeast complex,
the human Nup42GBM and DDX19 binding sites are on opposite
sides of the Gle1CTD molecule (Fig. 5a). Most of the solvent
exposed residues in helices α2 and α4 from Gle1CTD are buried by
the interaction involving two major interaction interfaces (Fig. 5b,
c). In the ﬁrst interface (interface 1), Gle1CTD residues of helix α4
(H495, E491, and Q487) form an extensive hydrogen bond
network with each other and DDX19CTD main chain atoms
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(residues 380–382), as well as a salt bridge between Gle1CTD
residue E491 and DDX19CTD residue K385 (Fig. 5b). In the
second interface (interface 2), the acidic C-terminal helix of
DDX19CTD is recognized by lysines on the Gle1CTD surface, with
salt bridges forming between DDX19CTD residues D470, D472,
and E475 and Gle1CTD residues K416, K419, and K479 (Fig. 5c).
In several instances, DDX19CTD residues (G329, T332, A334, and
L471) packed directly against Gle1CTD helices, interdigitating
between the sidechains to form hydrophobic interactions (Fig. 6b).
Single amino acid substitutions in Gle1CTD at these interfaces
were sufﬁcient to disrupt Gle1CTD-mediated stimulation of
DDX19 (Fig. 5e).
We next searched for the structural differences between the
human and yeast complexes that allow the human complex to
form in the absence of IP6 (Fig. 5f). In the structure of S.
cerevisiae Gle1CTD•IP6•Dbp5ΔN90(ADP), the interface between
Gle1CTD and Dbp5CTD is only ~700 Å2 in surface area, compared
to ~1300 Å2 for the human complex, a difference compensated
for in yeast through extensive contacts made by both proteins
with a bridging IP6 molecule (Supplementary Figs. 5a, 10a). For a
summary of differences, see Supplementary Note 4. These
observed structural differences result in a dramatic reduction of
the local electrostatic potential at the human Gle1CTD
−DDX19CTD interface compared to the yeast Gle1CTD
−DDX19CTD interface (Supplementary Fig. 17a, b). Thus, for S.
cerevisiae Dbp5 activation, the extreme negative charge of the IP6
molecule would be necessary to overcome the electrostatic
repulsion generated in forming such a positively charged pocket,
but for human DDX19 this requirement no longer exists. To test
whether IP6 was indeed unable to bind, we also determined
crystal structures of the human Gle1CTD•Nup42GBM•
DDX19ΔN53 complex grown in the presence of IP6 or soaked
with IP6, but observed no electron density for IP6 in these crystals
(Supplementary Fig. 17d, e; Supplementary Table 4).
To gain further insight into how Gle1CTD•Nup42GBM binding
facilitates DDX19 activation, we compared the structures of
Gle1CTD•Nup42GBM•DDX19ΔN53 to those of apo DDX19ΔN53.
The most apparent difference was a rotation of both DDX19NTD
and the auto-inhibitory helix away from DDX19CTD, despite the
auto-inhibitory helix still being bound between the
two domains (Fig. 6a). In the structure of S. cerevisiae
Gle1CTD•IP6•Dbp5ΔN90(ADP), Dbp5NTD is rotated even further
away from Dbp5CTD leading Dbp5NTD to also contact Gle1CTD
(Fig. 5f)10. In yeast, a Gle1CTD triple amino acid substitution
(V513D/A516D/I520D) at the Dbp5NTD binding interface
abolishes Gle1-mediated stimulation of Dbp510. A homologous
triple amino acid substitution in human Gle1CTD (G666D/I669D/
Q673D, DDD mutant) similarly abolished Gle1CTD-mediated
stimulation of DDX19, suggesting that the human proteins can
also form the fully rotated conformation observed for the S.
cerevisiae complex (Supplementary Fig. 13f). Therefore, we
considered our structure as an early intermediate state that
forms immediately after Gle1CTD binding to DDX19, but before
release of the auto-inhibitory helix and separation of DDX19NTD
and DDX19CTD.
We next searched for the conformational changes in
DDX19CTD that might explain how Gle1CTD-binding would
stimulate ATPase activity. Several differences could be attributed
to Gle1CTD binding, including contacts causing ordering of the C-
terminal helix and rearrangement of the trigger loop (residues
328–335) (Fig. 6a, b). Through direct interactions between
neighboring residues and relief of steric constraints, these changes
propagated to the adjacent anchor loop (residues 390–403)
(Fig. 6a, b). Remodeling of the anchor loop removes contacts
between DDX19CTD and the auto-inhibitory helix, resulting in
partial separation of DDX19NTD and DDX19CTD (Fig. 6c).
Remodeling of the anchor loop also results in ordering of a loop
containing ATP-binding residues in DEAD-box motif VI
(Fig. 6d). For details, see Supplementary Note 5. In summary,
Gle1CTD binding to DDX19CTD causes a cascade of conforma-
tional changes that partially releases the auto-inhibitory helix and
prepares the residues involved in nucleotide binding to form the
closed, active conformation.
Human Gle1•Nup42 relieves auto-inhibition. Our structural
data are consistent with a mechanism wherein relief from inhi-
bition by the N-terminal auto-inhibitory helix is one of the pri-
mary mechanisms for Gle1CTD stimulation of DDX19 activity.
Removal of the N-terminal 90 residues of S. cerevisiae Dbp5
increases unstimulated Dbp5 activity, but does not increase Gle1-
stimulated activity10. Similarly, removal of the N-terminal 53
residues also increased DDX19 activity, but activity in the pre-
sence of Gle1CTD could not be examined43. To obtain a better
understanding of the role of various regulatory elements in the N-
terminal region of human DDX19, we tested the activation of a
series of truncation variants that included DDX19ΔN53,
DDX19ΔN67, DDX19ΔN91, and a variant of full-length DDX19,
DDX19S60D/K64D, containing two aspartate substitutions in the
auto-inhibitory helix that would disrupt the inhibited state
(Supplementary Fig. 18a; See Supplementary Note 6 for a detailed
description of variants).
All four variants had higher basal ATPase activity than wild-
type DDX19, consistent with inhibitory roles for the disrupted
sequences (Fig. 7a). Removal of the entire unstructured N-
terminal extension, DDX19ΔN53, yielded ~2.5-fold higher basal
ATPase activity, which was similar to the reported ~3-fold higher
basal ATPase activity upon removal of the entire Dbp5 N-
terminal extension (Fig. 7a)10. Further N-terminal truncations,
DDX19ΔN67 and DDX19ΔN91, as well as the DDX19S60D/K64D
double amino acid substitution, exhibited ~7.5-fold higher basal
activity (Fig. 7a). Strikingly, in contrast to wild-type DDX19, the
activity of all four DDX19 variants was not stimulated by
Gle1CTD•Nup42GBM, but instead was inhibited to an activity level
comparable to wild-type DDX19 (Fig. 7a). Moreover, RNA
stimulated DDX19 activity in the absence of Gle1CTD•Nup42GBM
for the DDX19 variants, yielding rates between ~2-fold to ~10-
fold faster than wild-type DDX19 (Fig. 7a). For wild-type DDX19,
addition of both RNA and Gle1CTD•Nup42GBM resulted in
greater stimulation than either alone. However, for the variants
Fig. 4 Role of Nup42, RNA, and IP6 in Dbp5/DDX19 activation. a Steady-state colorimetric ATPase assay with S. cerevisiae Dbp5 performed at 30 and 37 °
C with either puriﬁed S. cerevisiae Gle1CTD or Gle1CTD•Nup42GBM. Reactions were performed with 0.5 μM Dbp5, 1.0 μM Gle1CTD or Gle1CTD•Nup42GBM,
0.1 mg/ml polyA RNA, and 2.0 μM IP6. Values shown are the average of three experiments. Error bars indicate the standard deviation. See also
Supplementary Fig. 13. b Steady-state colorimetric ATPase assay with H. sapiens DDX19 performed at 30 and 37 °C with either puriﬁed H. sapiens Gle1CTD
or Gle1CTD•Nup42GBM. Reactions were performed with 2.5 μM DDX19, 5.0 μM Gle1CTD or Gle1CTD•Nup42GBM, 0.1 mg/ml polyA RNA, and 10.0 μM IP6.
Values shown are the average of three experiments. Error bars indicate the standard deviation. See also Supplementary Fig. 13. c RNA dependence of S.
cerevisiae Dbp5 activation using the same conditions as in a, but with the indicated amounts of RNA performed at 30 and 37 °C. d RNA dependence of H.
sapiens DDX19 activation using the same conditions as in b, but with the indicated amounts of RNA performed at 30 and 37 °C. e IP6 dependence of
(left) S. cerevisiae Dbp5 or (right) H. sapiens DDX19 activation using the same conditions as in a or b, respectively, but with the indicated amounts of IP6
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that perturbed the auto-inhibitory helix, addition of both RNA
and Gle1CTD•Nup42GBM yielded only a barely detectable further
stimulation over RNA-mediated levels, resulting in fully stimu-
lated activities ~2- to 3-fold faster than wild-type DDX19
(Fig. 7a). In contrast, the truncation variant that still possessed
an intact auto-inhibitory helix, DDX19ΔN53, exhibited a ~2-fold
slower fully stimulated activity than wild-type.
These data explain several features of DDX19 activation. First,
although human DDX19 has ~7.5-fold lower ATPase activity
than Dbp5, a large part of this difference can be attributed to the
auto-inhibitory helix present in human DDX19 but not yeast
Dbp5, as disruption of this helix yields activities only ~3-fold
slower than fully stimulated Dbp5. Second, the N-terminal 53
residues of DDX19 that precede the auto-inhibitory helix have a
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subtle but distinct role, possibly similar to the role of the N-
terminal residues in yeast Dbp5. Lastly, the weak Gle1-mediated
stimulation of the hyperactive variants in the presence of RNA
suggests that relief from auto-inhibition is indeed a major
mechanism for Gle1-mediated stimulation.
Human Nup214 is stimulatory in the presence of Gle1. We next
analyzed the effect of the nucleoporin and mRNA export factor
Nup214 on DDX19 activation in the context of
Gle1CTD•Nup42GBM stimulation. Nup214NTD binds to
DDX19NTD via an interface that partially overlaps with the RNA
binding interface, and consequently, binding of Nup214NTD to
DDX19NTD impairs RNA binding and RNA-mediated stimula-
tion of DDX19 ATPase activity14,15. In yeast, Nup214NTD
enhances ADP release from Dbp5 but the consequence of this
effect is unclear, as Gle1CTD stimulates Dbp5 to the same activity
levels in the presence and absence of Nup214NTD10,44.
In the human system, addition of Nup214NTD did not affect
basal DDX19 ATPase activity or activity in the presence of
Gle1CTD•Nup42GBM (Fig. 7b). Consistent with previous reports,
Nup214NTD inhibited RNA-mediated stimulation (Fig. 7b)14,15.
However, when DDX19 was stimulated by both
Gle1CTD•Nup42GBM and RNA, the addition of Nup214NTD
further increased ATPase activity (Fig. 7b). This effect was
concentration dependent and more pronounced when Gle1CTD•-
Nup42GBM was present in substoichiometric amounts (Fig. 7c).
Thus, unlike what was found for the yeast system, Nup214NTD
can have a stimulatory effect in the context of Gle1-mediated
DDX19 stimulation10. We next utilized an electrophoretic
mobility shift assay to probe the effects of Gle1CTD•Nup42GBM
and Nup214NTD on RNA binding by DDX19. Whereas
Gle1CTD•Nup42GBM enhanced DDX19 binding to RNA,
Nup214NTD inhibited DDX19 binding to a 53-nucleotide
single-stranded RNA (Fig. 7d). However, Gle1CTD•Nup42GBM
rescued RNA binding in the presence of Nup214NTD, consistent
with its ability to rescue DDX19 from Nup214NTD inhibition
(Fig. 7b, d). Thus, Nup214 not only recruits DDX19 to the
cytoplasmic face of the NPC, but can also play an active role in
promoting DDX19 ATPase activity (See Supplementary Note 7).
Human disease mutations in Gle1. Several human diseases have
been linked to Gle1 dysfunction, including ALS, Huntington’s
disease, and the related disorders LCCS1 and LAAHD, which lead
to spinal cord motor neuron atrophy and premature death, often
prior to birth30,33,34. For ALS and LCCS1/LAAHD, speciﬁc
mutations have been mapped to Gle1CTD. In ALS, three muta-
tions have been associated with Gle1: a nonsense mutation that
results in a truncated protein after residue 70, a splice site
mutation that replaces the C-terminal 44 residues of Gle1CTD
with a novel 88-residue sequence, and a missense mutation
leading to the amino acid substitution R697C34. LCCS1 and
LAAHD are related disorders, in which the more phenotypically
severe LCCS1 patients are typically homozygous for a 3-residue
insertion at position 144 in the coiled-coil region of Gle1
(FinMajor) and the less phenotypically severe LAAHD patients are
compound heterozygous for the FinMajor mutation and a muta-
tion in Gle1CTD (V617M and I684T)33. The R569H variant in
Gle1CTD was identiﬁed in a patient diagnosed with the more
severe LCCS1, suggesting it has a more potent effect than the
V617M and I684T variants.
When mapped onto the structure of
Gle1CTD•Nup42GBM•DDX19ΔN53, none of the four amino acid
substitutions directly participated in binding to Nup42 or DDX19
(Fig. 7e; Supplementary Fig. 19a−d). We next evaluated the
Gle1CTD•Nup42GBM variants for thermostability and ability to
stimulate DDX19. All three LCCS1/LAAHD mutations possessed
altered thermostability that correlated with their phenotypic
disease manifestation, with the R569H variant exhibiting the
largest difference in Tm, from 50 °C for wild-type protein to 40 °C
for the disease variant (Fig. 7f). In contrast, there were no
substantial defects in ATPase stimulation for any of the disease
variants (Fig. 7g). In our crystal structures, R569 is involved in an
extensive network of intra-molecular interactions (Supplementary
Fig. 19a), whereas V617 and I684 are both buried in hydrophobic
cores (Supplementary Fig. 19b, c), supporting the conclusion that
these mutations reduce the stability of Gle1 rather than affecting
their ability to stimulate the activity of DDX19. Future work will
need to address whether Gle1 stability is also a contributing factor
in human disease.
Discussion
Using an interdisciplinary approach, we have garnered insight
into the mRNA export events that occur at the cytoplasmic face of
the NPC. Gle1CTD plays an important organizational role by
providing spatially separated binding sites for Nup42GBM and the
DEAD-box helicase DDX19/scDbp5. Strikingly, the
Gle1CTD•Nup42GBM interaction mechanism is virtually identical
in species separated by more than a billion years of evolution. A
comprehensive structure-function analysis of DDX19 indicates
that binding of Gle1CTD•Nup42GBM induces a conformational
change in DDX19, thereby stimulating its ATPase activity. Bio-
chemical analyses of Gle1 variants associated with human disease
suggest that nucleoporin stability is a contributing factor in motor
neuron disease.
While this paper was in revision, another group reported that
both Nup42 and IP6 directly affect Gle1-mediated
DDX19 stimulation45. Informed by our studies of Gle1CTD
thermostability, we attribute the observed stimulation by
Nup42GBM to its role in increasing Gle1CTD stability, rather than
a direct role in activation. In the yeast system, we also observed
apparent stimulation by Nup42GBM at 37 °C, which is the tem-
perature used in the other study46. However, our thermostability
experiments indicate that at 37 °C, Gle1CTD solubility is com-
promised (Fig. 2b). In contrast, stimulation by Nup42GBM at 30 °
C was largely undetectable (Supplementary Fig. 13c). This con-
clusion is further supported by examination of the crystal
Fig. 5 Structure of the human Gle1CTD•Nup42GBM•DDX19ΔN53 complex. a Crystal structure of H. sapiens Gle1CTD•Nup42GBM•DDX19ΔN53(ADP). Motifs
of interest are colored and labeled: auto-inhibitory helix (residues 54–67, purple); mobile loop (residues 68–91, blue); trigger loop (residues 328–335,
yellow); anchor loop (residues 390–403, cyan); motif VI (residues 429–435, light cyan); C-terminal helix (residues 468–479, magenta). Boxes indicate the
regions shown to the right. b, c Close-up views of critical complex-forming interactions in interfaces 1 and 2. d Left: crystal structure of H. sapiens
Gle1CTD•Nup42GBM•DDX19ΔN53(AMP-PNP•Mg2+). DDX19 is colored magenta for clarity. Right: Superposition of the ADP and AMP-PNP•Mg2+ bound
structures. e Analysis of the effect of single amino acid substitutions in the Gle1-DDX19 interface on Gle1-mediated stimulation of DDX19, using the same
conditions as in Fig. 4b at 37 °C. Values shown are the average of three experiments. Error bars indicate standard deviation. f Left: crystal structure of S.
cerevisiae Gle1CTD•IP6•Dbp5ΔN90(ADP) (PDB ID 3RRN)10. Right: superposition of the S. cerevisiae and H. sapiens structures. The arrow indicates the
rotation relating the conformations observed in the two crystal structures. Circles highlight structural differences. See also Supplementary Fig. 17
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structures, which revealed that Nup42GBM binds Gle1CTD on the
opposite face as the scDbp5/DDX19-binding interfaces. Fur-
thermore, we did not detect any stimulatory effect of Nup42GBM
in the human system.
In addition, we found that unlike yeast Dbp5, human DDX19
activation by Gle1CTD does not require IP6. This conclusion was
supported by multiple lines of evidence: (1) robust and indis-
tinguishable ATPase stimulation of human DDX19 by Gle1CTD
both in the presence and absence of IP6, (2) human Gle1CTD and
DDX19 formed a complex in SEC experiments in the absence of
IP6, (3) no binding of IP6 to human Gle1CTD•Nup42GBM was
detected in ITC experiments, (4) crystal structures uncover that
the human Gle1 pocket corresponding to the yeast Gle1 IP6
binding pocket possesses a dramatically reduced positive elec-
trostatic surface potential, (5) IP6 coordinating residues in yeast
Dbp5 were not conserved in human DDX19, and (6) no electron
density for IP6 was observed in crystal structures of human
Gle1CTD•Nup42GBM•DDX19ΔN53 determined using crystals
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soaked or co-crystallized with IP6. We note that our studies were
all performed with extensively puriﬁed proteins recombinantly
expressed in bacteria (Supplementary Fig. 13a, b) whereas DDX19
was puriﬁed from an insect cell expression system in the other
study45. Future work needs to assess whether other proteins,
small molecules, or post-translational modiﬁcations play a role in
regulating DDX19 activity.
Combining these results, we can propose a working model of
the DDX19 catalytic cycle (Fig. 8; Supplementary Movie 3).
DDX19 is predominantly trapped in the auto-inhibited state,
which can form in the presence of either ATP or ADP, although
the ATP- and ADP-bound states could exhibit different dynamics
for release of the auto-inhibitory helix. Gle1 binding facilitates
release from auto-inhibition by ﬁrst inducing conformational
rearrangements in DDX19CTD that partially open DDX19 and
generate a cleft between DDX19NTD and DDX19CTD (Fig. 8, step
1). Nup214NTD binding can accelerate the opening of the
domains leading to complete separation of the DDX19NTD and
DDX19CTD, forming the conformation observed in the structure
of S. cerevisiae Gle1CTD•IP6•Dbp5ΔN90 (Fig. 8, step 2). Separation
of DDX19NTD and DDX19CTD opens the nucleotide-binding
pocket and enables exchange of ADP for ATP (Fig. 8, step 3). The
auto-inhibitory helix could rebind and DDX19 would cycle
between open and closed conformations until it encounters RNA
(Fig. 8, step 4). RNA binding favors the formation of the closed,
catalytically active state and based on crystallographic data, would
also trigger release of Gle1 due to rearrangements in DDX19.
Speciﬁcally, the auto-inhibitory helix displaces DDX19’s C-
terminal helix and the mobile loop connecting the auto-
inhibitory helix resulting in a conformation that is incompatible
with Gle1 binding (Fig. 8, step 5). This process leads to dis-
placement of Nxf1•Nxt1, although future studies are necessary to
establish how DDX19 speciﬁcally removes Nxf1•Nxt1. After ATP
hydrolysis and subsequent dissociation of Pi and RNA, DDX19
would then recycle back to the inhibited state and another cycle of
ATP hydrolysis could then occur (Fig. 8, step 6).
There remains a substantial gap between rates of ATP hydro-
lysis measured in vitro (~1 ATP/second) and rates of mRNA
export termination observed in vivo (<0.1 s per mRNA)46,47. A
portion of this gap could be explained by a speciﬁc spatial
organization at the cytoplasmic face of the NPC that efﬁciently
accelerates the DDX19 cycle. Mapping of the Gle1-binding site on
Nup155 provides a critical spatial restraint for the location of
Gle1 and the entire cytoplasmic ﬁlament subcomplex in the NPC.
Attempts to dock the newly determined structures of the human
Gle1CTD•Nup42GBM•DDX19ΔN53 into the cryoelectron tomo-
graphic reconstruction of the intact human NPC did not identify
any unambiguous placements, although the rapid binding
kinetics of DDX19 at the NPC suggest that it may not be present
in the reconstructions (Supplementary Fig. 20)48,49. Furthermore,
all of the cytoplasmic ﬁlament proteins studied here contain
additional domains that may play important roles in DDX19
activity regulation. However, a complete characterization of these
effects is expected to require the reconstitution of a fully assem-
bled cytoplasmic ﬁlament nucleoporin complex, including the
remaining domains of Nup42, Nup214, Gle1, their FG repeats,
and their binding partners. This complex will need to be
assembled onto the human CNC rings that serve as a scaffold in
the intact NPC and assayed with Nxf1•Nxt1-bound mRNAs. The
results presented here provide a rich foundation for the design of
these experiments.
Lastly, the effect of Nup42 on Gle1 stability highlights protein
instability as a potent modiﬁer of Gle1 function, as the Gle1CTD
fold is unstable at physiological temperatures in vitro in the
absence of its cofactors. The effects of mutations associated with
human disease in our thermostability experiments largely corre-
lated with their phenotypic severity, suggesting that protein sta-
bility may be a contributing factor in these diseases. Interestingly,
measurements of S. cerevisiae Gle1CTD•IP6 thermostability in the
absence of Nup42GBM in vitro matched the temperatures at
which we observed mislocalization of Gle1 in yeast cells, pre-
sumably a result of misfolding and subsequent dissociation from
the NPC (Fig. 2a). A similar phenomenon occurs in human cells,
as the mutations that destabilize human Gle1CTD have previously
been found to possess NPC localization defects49. Overall, our
results reinforce the link between mislocalization or aggregation
of proteins involved in RNA metabolism and nucleocytoplasmic
transport with human disease. Future studies that build upon the
results reported here to determine the contribution of protein
destabilization in disease models should provide greater insight
into the mechanisms underlying motor neuron disease.
Methods
Chemicals and reagents. Chemicals were purchased from Sigma at the highest
purity available unless otherwise noted.
Construct generation. DNA fragments were ampliﬁed using the polymerase chain
reaction. SUMO-tagged proteins were cloned into a modiﬁed pET28a vector50.
GST-tagged proteins were cloned into a pGEX-6P-1 vector. His6-tagged proteins
were cloned into a modiﬁed pET28a vector51. S. cerevisiae and H. sapiens
Gle1CTD•Nup42GBM were cloned into a modiﬁed pETDuet-1 vector with
Nup42GBM in the ﬁrst site and Gle1CTD in the second site. Mutants were generated
using the QuikChange mutagenesis protocol and conﬁrmed by DNA sequencing.
Details of bacterial expression constructs and expression conditions are shown in
Supplementary Table 5.
Protein expression and puriﬁcation. Proteins were expressed in E. coli BL21-
CodonPlus(DE3)-RIL cells (Stratagene) in Luria-Bertani media and induced at an
OD600 of ~0.6 with 0.5 mM IPTG (Gold Biotechnology). Unless indicated other-
wise, cells were harvested by centrifugation and resuspended in a buffer containing
20 mM TRIS (pH 8.0), 500 mM NaCl, 4 mM 2-mercaptoethanol (β-ME), and 15
mM imidazole, supplemented with complete EDTA-free protease inhibitor cocktail
(Roche) and ﬂash frozen in liquid nitrogen. Cells were supplemented with 1 mg
deoxyribonuclease I (Roche), lysed with a cell disruptor (Avestin), and centrifuged
at 4 °C and 30,000 × g for 1 h. Supernatants were loaded onto an Ni-NTA afﬁnity
column (GE Healthcare) equilibrated in a buffer containing 20 mM TRIS (pH 8.0),
500 mM NaCl, 4 mM β-ME, and 15 mM imidazole and eluted with a linear gra-
dient of imidazole concentration to 500 mM. Eluted proteins were dialyzed over-
night with a buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl, 4 mM β-ME,
and 15 mM imidazole and subsequently puriﬁed through afﬁnity, ion exchange,
and SEC.
hsGle1CTD•His6-hsNup42GBM variants, scGle1CTD•His6-scNup42GBM, and
His6-scGle1CTD were grown for 18 h at 18 °C. His6-ctGle1CTD was co-expressed
with GST-ctNup42GBM and grown for 3 h at 37 °C. After elution from the Ni-NTA
column, the His6 tag and the GST tag were removed by cleavage with PreScission
Fig. 6 Conformational changes in DDX19 induced by Gle1 binding. a Left: crystal structure of H. sapiens DDX19ΔN53(ADP) (PDB ID 3EWS)44. Disordered
regions (C-terminal helix and motif VI) are indicated with dashed lines. Middle: crystal structure of H. sapiens Gle1CTD•Nup42GBM•DDX19ΔN53(ADP)
shown in the same orientation and colored as in Fig. 5a. Right: superposition of the two structures. Arrows indicate the rotation relating the conformations
of DDX19ΔN53(ADP) in the presence and absence of Gle1CTD•Nup42GBM. The cartoon on the right schematizes the transition from the inhibited state to
the Gle1-bound state. See also Supplementary Fig. 16. b Zoom view of the DDX19 trigger loop (yellow) in (left) the inhibited state (PDB ID 3EWS), (middle)
the Gle1-bound state, and (right) their superposition. The cartoon on the right indicates the region of DDX19 shown. c Zoom view of the DDX19 anchor
loop (cyan) and auto-inhibitory helix (purple) in the (left) inhibited state (PDB ID 3EWS), (middle) the Gle1-bound state, and (right) their superposition.
The cartoon on the right indicates the region of DDX19 shown. d Zoom view of DDX19 Motif VI in (left) the inhibited state (PDB ID 3EWS), (middle) the
Gle1-bound state, and (right) the RNA-bound state (PDB ID 3G0H)44. The cartoon on the right indicates the region of DDX19 shown
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Fig. 7 Biochemical analysis of DDX19 activity. a Steady-state ATPase activity of DDX19 variants in the presence and absence of RNA and
Gle1CTD•Nup42GBM. For schematics of the various truncation constructs, see Supplementary Fig. 18a. b Analysis of the effect of Nup214NTD on
DDX19 stimulation. See also Supplementary Fig. 18. c Analysis of concentration dependence of Nup214NTD on DDX19 stimulation in the presence of RNA
and Gle1CTD•Nup42GBM. d Electrophoretic mobility shift assay analysis of the effect of Gle1CTD•Nup42GBM (1 μM) and Nup214NTD (2 μM) on DDX19 (1
μM) binding to a 53-nucleotide ssRNA. RNA was visualized by staining with SYBR gold. The proteins loaded in each lane were also visualized with a
Coomassie-stained SDS-PAGE gel, shown below. eMapping single amino acid substitutions associated with human diseases LCCS1/LAAHD and ALS onto
the structure of Gle1CTD•Nup42GBM•DDX19ΔN53(ADP). Coloring is the same as in Fig. 5a. See also Supplementary Fig. 19. f Differential scanning
ﬂuorimetry analysis of the effect of human disease mutations on Gle1CTD•Nup42GBM stability. Exposure of hydrophobic residues monitored by an increase
in relative ﬂuorescence units (RFUs). Curves represent the average of three experiments. g Steady-state ATPase activity of DDX19 stimulation by Gle1CTD
variants containing single amino acid substitutions associated with human disease. All reported values are the average of three experiments. Error bars
indicate standard deviation
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protease concurrent with dialysis. Dialyzed protein was loaded onto an Ni-NTA
column equilibrated in a buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl, 4
mM β-ME, and 15 mM imidazole. Protein-containing fractions were pooled and
loaded onto a HiTrap Heparin HP column (GE Healthcare) equilibrated in a buffer
containing 20 mM TRIS (pH 8.0), 100 mM NaCl, and 5 mM dithiothreitol (DTT)
and eluted with a linear gradient of NaCl concentration to 2M. Protein-containing
fractions were concentrated and loaded onto a HiLoad Superdex 75 16/60 PG
column (GE Healthcare) equilibrated in a buffer containing 20 mM TRIS (pH 8.0),
100 mM NaCl, and 5 mM DTT.
His6-SUMO-hsGle1CTD was grown for 18 h at 18 °C and puriﬁed as
hsGle1CTD•His6-hsNup42GBM, except the His6-SUMO tag was removed by Ulp1
cleavage.
His6-hsDDX19 variants, His6-scDbp5 and His6-SUMO-ctDbp5 were grown for
18 h at 18 °C. Cells were harvested by centrifugation and resuspended in a buffer
containing 20 mM TRIS (pH 8.0), 500 mM NaCl, 4 mM β-ME, 15 mM imidazole,
and 5% (v/v) glycerol, supplemented with Complete EDTA-free protease inhibitor
cocktail (Roche) and ﬂash frozen in liquid nitrogen. After lysis and centrifugation,
the supernatant was loaded onto an Ni-NTA column equilibrated in a buffer
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Fig. 8 Proposed working model for the DDX19 catalytic cycle. a Schematic cartoon of the DDX19 catalytic cycle. b Schematic of the DDX19 catalytic cycle
with crystal structures of each state. The inhibited conformation corresponds to the crystal structure of DDX19ΔN53(ADP) (PDB ID 3EWS)44. The closed
Gle1-bound conformations correspond to the crystal structures of Gle1CTD•Nup42GBM•DDX19ΔN53(AMP-PNP•Mg2+) and
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Gle1CTD•IP6•Dbp5ΔN90(ADP)•Nup159NTD (PDB IDs 3RRM and 3RRN)10. The RNA bound conformation corresponds to the crystal structure of
DDX19ΔN53(AMP-PNP•Mg2+)•U10 RNA (PDB IDs 3RRM and PDB ID 3G0H)44. Gle1CTD•Nup42GBM and Nup214NTD correspond to the apo structures
(PDB ID 2OIT)69
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containing 20 mM TRIS (pH 8.0), 500 mM NaCl, 4 mM β-ME, 15 mM imidazole,
and 5% (v/v) glycerol. Protein was eluted with a linear gradient of imidazole
concentration to 500 mM and protein-containing fractions were dialyzed overnight
in a buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl, 4 mM β-ME, 15 mM
imidazole, and 5% (v/v) glycerol. The His6 tags of His6-DDX19 variants and His6-
scDbp5 were cleaved using PreScission protease concurrent with overnight dialysis.
The His6-SUMO tag of His6-SUMO-ctDbp5 was cleaved with Ulp1 protease and
the cleaved protein was desalted with dialysis buffer immediately after elution from
the Ni-NTA column. The dialyzed/desalted protein was loaded onto an Ni-NTA
column equilibrated in a buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl, 4
mM β-ME, 15 mM imidazole, and 5% (v/v) glycerol. Protein-containing
ﬂowthrough fractions were loaded onto a HiTrap Q HP column (GE Healthcare)
equilibrated in a buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl, 5 mM
DTT, and 5% (v/v) glycerol and eluted with a linear gradient of NaCl concentration
to 2M. Protein-containing fractions were concentrated and loaded onto a HiLoad
Superdex 200 16/60 PG column (GE Healthcare) equilibrated in a buffer
containing 20 mM TRIS (pH 8.0), 100 mM NaCl, 5 mM DTT, and 5% (v/v)
glycerol.
His6-SUMO-hsGle1N and variants were grown at 30 °C for 2 h after IPTG
induction. After elution from the Ni-NTA column, proteins were dialyzed
overnight in a buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl, and 5 mM
DTT. After dialysis, proteins were loaded onto a HiTrap Q HP column and eluted
with a linear gradient of NaCl concentration to 2M. Protein-containing fractions
were concentrated and loaded onto a Superdex 200 10/300 GL column (GE
Healthcare) equilibrated in a buffer containing 20 mM TRIS (pH 8.0), 100 mM
NaCl, and 5 mM DTT.
His6-SUMO-scNup42GBM-His6 and variants were grown at 37 °C for 2 h after
IPTG induction. After elution from the Ni-NTA column, the His6-SUMO tag was
removed by cleavage with Ulp1 concurrent with overnight dialysis into a buffer
containing 20 mM TRIS (pH 8.0), 100 mM NaCl, and 5 mM DTT. After dialysis,
proteins were injected onto a HiTrap Q HP column and collected in the
ﬂowthrough. Protein-containing fractions were concentrated and loaded onto a
Superdex Peptide 10/300 GL column (GE Healthcare).
His6-Nup155CTD and His6-Nup214NTD were grown for 18 h at 18 °C after
IPTG induction. After elution from the Ni-NTA column, proteins were dialyzed
overnight in 20 mM TRIS (pH 8.0), 500 mM NaCl, 4 mM β-ME, and 15 mM
imidazole. His6 tags were removed by cleavage with PreScission protease
concurrent with dialysis. Dialyzed protein was loaded onto an Ni-NTA column
equilibrated in a buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl, 4 mM β-
ME, and 15 mM imidazole. Protein-containing fractions were pooled and loaded
onto a HiTrap Q HP column equilibrated in a buffer containing 20 mM TRIS (pH
8.0), 100 mM NaCl, and 5 mM DTT and eluted with a linear gradient of NaCl
concentration to 2M. Protein-containing fractions were concentrated and loaded
onto a HiLoad Superdex 200 16/60 PG column equilibrated in a buffer containing
20 mM TRIS (pH 8.0), 100 mM NaCl, and 5 mM DTT.
His6-SUMO-Nup98ΔFG was puriﬁed as Nup155CTD and Nup214NTD, except
the His6-SUMO tag was removed by cleavage with Ulp1.
GST-Nup155CTD was grown for 18 h at 18 °C after IPTG induction. After
harvesting, lysis, and centrifugation, supernatant was loaded onto a Glutathione
Sepharose 4 Fast Flow column (GE Healthcare) equilibrated in a buffer containing
20 mM TRIS (pH 8.0), 150 mM NaCl, and 5 mM DTT. GST-Nup155CTD was
eluted with a linear gradient of reduced glutathione concentration to 10 mM.
Protein-containing fractions were loaded onto a HiTrap Q HP column equilibrated
in a buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl, and 5 mM DTT and
eluted with a linear gradient of NaCl concentration to 2M. Protein-containing
fractions were concentrated and loaded onto a HiLoad Superdex 200 16/60 PG
column equilibrated in a buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl,
and 5 mM DTT.
Crystallization and structure determination. S. cerevisiae Gle1CTD•Nup42GBM
was crystallized at 23 °C with the hanging drop method using 1 μl of protein
solution (22.5 mg/ml) and 1 μl of reservoir solution, containing 0.1 M HEPES (pH
8.2), 11% (w/v) PEG 3350, and 0.2 M L-Proline. Crystals were cryoprotected with a
solution identical to the reservoir solution, but supplemented with 30% (v/v)
ethylene glycol. X-ray diffraction data were collected at beamline 12-2 at the
Stanford Synchotron Radiation Lightsource (SSRL) with a wavelength of 0.9795 Å
and processed with the XDS package52. The structure was solved by molecular
replacement with Phaser, using the structure of Gle1CTD (PDB ID 3RRN) as a
search model10,53. The structure was reﬁned using the PHENIX package with TLS
reﬁnement54. One of the Gle1 molecules in the asymmetric unit displays two
distinct conformations for half the molecule and was modeled as two alternate
conformations for the entire residue range. The ﬁnal structure was reﬁned to Rwork
and Rfree values of 18.5 and 21.1%, respectively, with excellent geometry (98.3% of
residues in favored region of the Ramachandran plot, 1.7% in the allowed region,
and 0.0% outliers; MolProbity clashscore 1.92; MolProbity score 0.96)55.
H. sapiens Gle1CTD•Nup42GBM was crystallized at 23 °C with the hanging drop
method using 1 μl of protein solution (20 mg/ml) and 1 μl of reservoir solution,
containing 0.2 M sodium potassium phosphate (pH 7.6) and 26% (w/v) PEG 3350.
Crystals were cryoprotected by gradual supplementation of ethylene glycol in 5%
steps to a ﬁnal concentration of 30% (v/v). X-ray diffraction data were collected at
beamline 23-ID-D at the Advanced Photon Source (APS) with a wavelength of
0.9794 Å and processed with the XDS package52. The diffraction data were
anisotropic, with diffraction limits along the three principal components of 2.8, 3.1,
and 3.1 Å. The structure was solved by molecular replacement with Phaser, using
the structure of S. cerevisiae Gle1CTD (PDB ID 3RRN) as a search model10,53.
Reﬁnement was performed using torsion NCS restraints with the PHENIX package
using anisotropically truncated and scaled data generated using the UCLA-DOE
anisotropy server54,56. The ﬁnal structure was reﬁned to Rwork and Rfree values of
24.5 and 27.4%, respectively, with excellent geometry (95.2% of residues in favored
region of the Ramachandran plot, 4.8% in the allowed region, and 0.0% outliers;
MolProbity clashscore 1.88; MolProbity score 1.31)55.
C. thermophilum Gle1CTD•Nup42GBM was crystallized at 23 °C with the
hanging drop method using 1 μl of protein solution (10 mg/ml) and 1 μl of
reservoir solution, containing 0.1 M MES (pH 6.3) and 12% (w/v) PEG 20,000.
Crystals were cryoprotected by gradual supplementation of ethylene glycol in 5%
steps to a ﬁnal concentration of 25% (v/v). X-ray diffraction data were collected at
beamline 23-ID-D at APS with a wavelength of 1.0332 Å and processed with the
XDS package52. The structure was solved by molecular replacement with Phaser,
using the structure of H. sapiens Gle1CTD as a search model53. The structure was
reﬁned with torsion NCS restraints using the PHENIX package54. The ﬁnal
structure was reﬁned to Rwork and Rfree values of 24.0 and 27.7%, respectively, with
excellent geometry (97.5% of residues in favored region of the Ramachandran plot,
2.5% in the allowed region, and 0.0% outliers; MolProbity clashscore 3.34;
MolProbity score 1.22)55.
C. thermophilum Gle1CTD•Nup42GBM•IP6 was crystallized at 23 °C with the
hanging drop method using 1 μl of protein solution (7.5 mg/ml) and 1 μl of
reservoir solution, containing 10 mM zinc sulfate heptahydrate, 0.1 M MES (pH
6.3), and 18% (v/v) Polyethylene glycol monomethyl ether 550. Crystals were
improved by microseeding. Crystals were cryoprotected by gradual
supplementation of ethylene glycol in 5% steps to a ﬁnal concentration of 25% (v/
v). SeMet-labeled crystals were grown using the same conditions. X-ray diffraction
data were collected at beamline 12-2 at SSRL with a wavelength of 0.9792 Å for
SeMet crystals and 1.0332 Å for native crystals, and processed with the XDS
package52. The structure was solved using Crank2, using the structure of H. sapiens
Gle1CTD as an initial search model57,58. The structure was reﬁned using the
PHENIX package54. The presence of Zn2+ ions was conﬁrmed using anomalous
difference Fourier maps. The ﬁnal structure was reﬁned to Rwork and Rfree values of
19.3 and 23.0%, respectively, with excellent geometry (98.3% of residues in favored
region of the Ramachandran plot, 1.7% in the allowed region, and 0.0% outliers;
MolProbity clashscore 0.56; MolProbity score 0.69)55.
For crystallization of the H. sapiens Gle1CTD•Nup42GBM•DDX19ΔN53, the
complex was reconstituted by mixing equimolar amounts of puriﬁed
Gle1CTD•Nup42GBM and DDX19ΔN53 to form a 400 μM stock solution. The stock
solution was supplemented with 400 μM ADP or AMP-PNP and 400 μM MgCl2.
Protein stock solutions were diluted with a buffer containing 20 mM TRIS (pH
8.0), 100 mM NaCl, 5 mM DTT, 1 mM MgCl2, and 1 mM ADP or AMP-PNP.
Crystals of Gle1CTD•Nup42GBM•DDX19ΔN53(ADP) were grown at 4 °C with the
hanging drop method using 1 μl of protein solution (7.5 mg/ml) and 1 μl of
reservoir solution, containing 13% (w/v) PEG 3350 and 0.2 M sodium potassium
phosphate. Crystals of Gle1CTD•Nup42GBM•DDX19ΔN53(AMP-PNP•Mg2+) were
grown at 4 °C with the hanging drop method using 1 μl of protein solution (5 mg/
ml) and 1 μl of reservoir solution in 15% (w/v) PEG 3350 and 0.3 M sodium
potassium phosphate (pH 6.6). Crystals were cryoprotected by gradual
supplementation of ethylene glycol to a ﬁnal concentration of 25% (v/v) in 5% (v/v)
steps.
Diffraction data for Gle1CTD•Nup42GBM•DDX19ΔN53(ADP) were collected at
beamline 23-ID-D at APS with a wavelength of 1.0333 Å and processed with
XDS52. The diffraction data were anisotropic, with diffraction limits along the three
principal components of 3.6, 3.7, and 4.0 Å. The crystal structure was solved by
molecular replacement with Phaser, using the structure of H. sapiens
Gle1CTD•Nup42GBM and H. sapiens DDX19 (PDB ID 3EWS) as search models43.
Reﬁnement was performed using torsion NCS restraints with the PHENIX package
using anisotropically truncated and scaled data generated using the UCLA-DOE
anisotropy server54,56. The ﬁnal structure was reﬁned to Rwork and Rfree values of
23.2 and 28.1%, respectively, with excellent geometry (95.9% of residues in favored
region of the Ramachandran plot, 4.1% in the allowed region, and 0.0% outliers;
MolProbity clashscore 3.86; MolProbity score 1.45)55.
Diffraction data for Gle1CTD•Nup42GBM•DDX19ΔN53(AMP-PNP•Mg2+) were
collected at the Frontier Microfocusing Macromolecular Crystallography beamline
(FMX) at the National Synchotron Lightsource-II (NSLS-II) with a wavelength of
0.9793 Å. The crystals grew in space group P21 but were non-merohedrally twinned
with the twin domains related by a 180° rotation along a. Diffraction data were
integrated with DIALS and scaled with AIMLESS59,60. The structure was solved by
molecular replacement with Phaser, using the structures of H. sapiens
Gle1CTD•Nup42GBM and H. sapiens DDX19 (PDB ID 3EWS) as search
models43,53. The diffraction data were anisotropic, with diffraction limits along the
three principal components of 3.4, 3.7, and 4.2 Å. Reﬁnement was performed with
PHENIX using anisotropically truncated and scaled data generated with the
UCLA-DOE anisotropy server54,56. The ﬁnal structure was reﬁned to Rwork and
Rfree values of 26.1 and 31.3%, respectively, with excellent geometry (95.0% of
residues in favored region of the Ramachandran plot, 5.0% in the allowed region,
and 0.0% outliers; MolProbity clashscore 2.72; MolProbity score 1.43)55.
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For the structures of Gle1CTD•Nup42GBM•DDX19ΔN53(AMP-PNP•Mg2+)
grown in the presence of or soaked with IP6, crystals of
Gle1CTD•Nup42GBM•DDX19ΔN53(AMP-PNP•Mg2+) were grown in a drop
additionally supplemented with 0.5 mM IP6 or soaked for 4 days with 0.5 mM IP6,
respectively. Crystals grown or soaked with IP6 were cryoprotected with solutions
supplemented with 0.5 mM IP6. Diffraction data were collected at beamline 23-ID-
D at APS, integrated with DIALS and scaled with AIMLESS59,60. The structures
were solved by direct substitution of the coordinates of the structure of
Gle1CTD•Nup42GBM•DDX19ΔN53(AMP-PNP•Mg2+) and reﬁned with the
PHENIX package54. The structure of Gle1CTD•Nup42GBM•DDX19ΔN53(AMP-
PNP•Mg2+) soaked with IP6 was reﬁned to Rwork and Rfree values of 24.6 and
29.7%, respectively, with a MolProbity score of 1.3855. The structure of
Gle1CTD•Nup42GBM•DDX19ΔN53(AMP-PNP•Mg2+) co-crystallized with IP6 was
reﬁned to Rwork and Rfree values of 25.8 and 31.3%, respectively, with a MolProbity
score of 1.4155. Simulated annealing omit maps were calculated using the PHENIX
package by omitting all ligand molecules54.
Crystals of DDX19ΔN53(AMP-PNP•Mg2+) grew during crystallization trials of
Gle1CTD•Nup42GBM•DDX19ΔN53(AMP-PNP•Mg2+) in heavy precipitate. The
reservoir solution contained 0.1 M malonate, imidazole, borate (MIB) buffer (pH
5.0) and 13% (w/v) PEG 1500. Crystals were cryoprotected with the reservoir
solution supplemented with 20% (v/v) ethylene glycol. X-ray diffraction data were
collected at beamline 23-ID-D at APS with a wavelength of 1.0333 Å and the data
were integrated with DIALS and scaled with AIMLESS59,60. The crystal structure
was solved by molecular replacement using the structure of DDX19ΔN53(ADP)
(PDB ID 3EWS)43. The structure was reﬁned with TLS groups using the PHENIX
package54. The ﬁnal structure was reﬁned to Rwork and Rfree values of 20.7 and
24.8%, respectively, with excellent geometry (98.9% of residues in favored region of
the Ramachandran plot, 1.1% in the allowed region, and 0.0% outliers; MolProbity
clashscore 2.04; MolProbity score 0.97)55.
For details of the data collection and reﬁnement statistics for all structures, see
Supplementary Tables 1–4. For representative views of electron density for all
structures, see Supplementary Figure 21.
Analytical size-exclusion chromatography. Protein−protein interaction experi-
ments were carried out on a Superdex 200 10/300 GL or Superdex 75 10/300 GL gel
ﬁltration column equilibrated in a buffer containing 20 mM TRIS (pH 8.0), 100
mM NaCl, and 5 mM DTT (when present, 0.5 mM IP6 was added to the buffer).
The different combinations were mixed and incubated for 30 min on ice using a
twofold molar excess of the smaller component. Complex formation was evaluated
by comparing the mobility on the gel ﬁltration column of pre-incubated proteins
versus individual proteins. Complex formation was conﬁrmed by SDS-PAGE of the
protein-containing fractions, followed by Coomassie brilliant blue staining.
GST pull-down interaction analysis. Glutathione-S-transferase (GST) pull-down
experiments were performed with puriﬁed GST-Nup155CTD, Nup98ΔFG, and
SUMO-Gle1N. 25 μl of Glutathione Sepharose 4 Fast Flow beads (GE Healthcare)
were equilibrated with a buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl
and 5 mM DTT. GST-Nup155CTD (20 μM) was preincubated for 30 min with a
twofold molar ratio of either Nup98ΔFG or SUMO-Gle1N on ice. Preincubated
mixtures were subsequently incubated with 0, 0.5, 1, 1.5, 2, 4, or 8-fold molar ratios
of the other protein for another 30 min on ice. Mixtures were then incubated with
pre-equilibrated glutathione-coupled sepharose beads for 30 min and washed ﬁve
times with a buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl and 5 mM
DTT and centrifuged at 500 × g at 4 °C. Bound protein was eluted from the beads
with 25 μl buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl, 5 mM DTT, and
10 mM reduced glutathione.
Yeast strain generation. The nup42Δ/gle1-GFP strain was generated in a haploid
BY4741 parental strain by ﬁrst introducing the natNT2 cassette by homologous
recombination into the nup42 gene, followed by three rounds of selection on yeast
extract peptone dextrose (YPD) plates containing Nourseothricin (Gold Bio-
technology)61. Subsequently, a GFP-kanMX cassette was inserted into the C-
terminus of Gle1 followed by three rounds of selection on YPD plates containing
G41861. Nup42-mCherry-3xHA variants were introduced using a modiﬁed pRS415
plasmid followed by two rounds of selection on plates containing leucine-depleted
synthetic dextrose complete medium (SDC-LEU). For details of yeast strains and
constructs, see Supplementary Table 6.
Yeast live cell ﬂuorescence. Cells were grown in SDC-LEU medium to mid-log
phase at 30 °C and shifted to 42 °C for 3 h. For ﬂuorescence imaging, cells were
pelleted by centrifugation for 2 min at 650 × g, resuspended in water, and imaged
using a Carl Zeiss Observer Z.1 equipped with a Hamamatsu camera C10600
Orca-R2.
Yeast growth assay. For growth analysis, cells were grown in SDC-LEU medium at
30 °C to an OD600 of 0.2. Fifteen microliters of a tenfold dilution series was spotted
onto plates containing SDC-LEU medium, which were incubated at 30 and 37 °C.
Western blot analysis. The expression levels of Nup42-mCherry-3xHA variants
were assessed for the S. cerevisiae nup42Δ/gle1-GFP strain. Transformed cells were
selected twice on SDC-LEU plates before analysis. Protein extraction from cells was
performed via NaOH and SDS treatment, using a modiﬁed protocol62. Speciﬁcally,
cells were grown at 30 °C to an OD600 of ∼1.0 before harvesting 10 ml of culture by
centrifugation for 5 min at 3000 × g. Cell pellets were resuspended in 100 μl of 0.3
M NaOH and incubated for 5 min on ice, pelleted by centrifugation at 3000 × g,
washed with water twice, and resuspended in a buffer containing 20 mM TRIS (pH
8.0), 250 mM NaCl and 2% (w/v) SDS, incubated at 80 °C for 10 min followed by
centrifugation at 30,000 × g for 4 min. The supernatant was collected, diluted with
SDS loading dye, and boiled for 3 min prior to loading on a SDS-PAGE gel.
Western blot analysis of Nup42-mCherry-3xHA variants was performed with a 1 h
incubation at room temperature with mouse anti-HA antibody (Covance; MMS-
101P; 1:5000 dilution) and a 1 h incubation at room temperature with an anti-
mouse antibody coupled to alkaline phosphatase (Promega; S3721; 1:5000 dilution)
visualized by color development using SIGMAFAST 5-bromo-4-chloro-3-indolyl
phosphate (BCIP)/nitro blue tetrazolium (NBT) tablets (Sigma; B5655). Equal
loading was established with an overnight incubation at 4 °C with rabbit anti-
hexokinase antibody (US Biological; H2035-02; 1:10,000 dilution) and 1 h incu-
bation at room temperature with a goat anti-rabbit antibody fused to an IR800
ﬂuorescent probe (Li-Cor, 926-32211; 1:10,000 dilution) imaged with an IR imager
(Li-Cor Odyssey) using the 800 nm channels in a single scan at 169 μm resolution
and a scan intensity of 5. Antibodies were diluted in TBS-T supplemented with 3%
(w/v) milk powder and washes were carried out in TBS-T.
Differential scanning ﬂuorimetry assay. Differential scanning ﬂuorimetry was
performed using a previously described protocol63. Using a real-time PCR
instrument (Bio-Rad C1000 96-well Thermal Cycler), ﬂuorescence of a 20 μl
mixture of 5 μM puriﬁed protein and 5× SYPRO orange dye (Invitrogen) was
measured once per minute while the temperature was increased 1 °C/min from 4 to
95 °C. Reactions were performed in 20 mM TRIS (pH 8.0), 100 mM NaCl, and 5
mM DTT. When present, IP6 was supplemented to 25 μM for yeast proteins and
100 μM for human proteins. The reported Tm values were determined by ﬁnding
the temperature corresponding to the maximum of the ﬁrst derivative of the
thermal melting curve. Traces represent the average of three experiments.
Pelleting thermostability assay. Fifty-microliter samples of puriﬁed protein (10
μg each) were incubated for 30 min at indicated temperatures between 25 and 55 °
C. Soluble and pellet fractions were isolated by centrifugation at 30,000 × g for 35
min at 4 °C. Reactions were performed in a buffer containing 20 mM TRIS (pH
8.0), 100 mM NaCl, and 5 mM DTT. When present, IP6 was added to a ﬁnal
concentration of 20 μM. Proteins were resolved by SDS-PAGE gel and visualized
with Coomassie brilliant blue staining.
NADH-coupled ATPase assay. Steady-state ATPase activity rates were deter-
mined at 30 and 37 °C for scDbp5 and hsDDX19 using previously established
conditions41. The reaction mixture (80 μl) contained puriﬁed scDbp5 and
hsDDX19 (WT and variants) at 0.5 and 2.5 μM, respectively. Unless otherwise
noted, all other S. cerevisiae and H. sapiens proteins (Gle1CTD, Gle1CTD•-
Nup42GBM, or Nup214NTD) were present at concentrations of 1 and 5 μM,
respectively. When present, polyA RNA with length ranging between 465 and 660
bases (GE Healthcare, 27411001) was added to a ﬁnal concentration of 0.1 mg/ml.
When present, IP6 was supplemented to a ﬁnal concentration of 2 and 10 μM for
yeast and human, respectively, unless otherwise noted. The reaction mixture
contained 30 mM HEPES (pH 7.5), 100 mM NaCl, 2 mM MgCl2, 1 mM DTT, 6
mM phosphoenolpyruvate (PEP, Alfa Aesar), 1.2 mM NADH, 1.6 μl pyruvate
kinase (PK)/lactate dehydrogenase enzyme solution (LDH), and 2.5 mM ATP,
unless otherwise noted.
For each reaction, two separate mixtures were prepared and kept separate until
initiation of the reaction. The ﬁrst mixture, containing the protein components,
IP6, polyA RNA, and buffer (HEPES, NaCl, and MgCl2), was prepared to a ﬁnal
volume of 20 μl and incubated on ice. The second mixture, containing buffer, DTT,
PEP, NADH, ATP, and PK/LDH, was prepared to a ﬁnal volume of 60 μl and
dispensed into a 96-well plate. Reactions were initiated by addition of the protein
mixture. Plates were centrifuged at 4000 × g for 2 min at 4 °C prior to being loaded
in the pre-warmed plate reader. A340 was measured every 30 s for 30 min using a
FlexStation 3 microplate reader (Molecular Devices). Rates were calculated by
ﬁtting the linear portion of the reaction. Reported rates were determined by
dividing the rate of ATP consumption by the concentration of DDX19/Dbp5 in the
reaction. All values reported are the average of three experiments.
Isothermal titration calorimetry experiments. ITC measurements were per-
formed at 21 °C using a MicroCal ITC200 Calorimeter (GE Healthcare/Malvern) in
a buffer containing 100 mM HEPES (pH 7.4), 100 mM NaCl, 2 mM MgCl2, and 4
mM β-ME. Protein solutions were dialyzed overnight against ITC buffer and IP6
was dissolved in the dialysate. All measurements were performed in triplicate.
Because of the acidic nature of IP6, the heat generated from dilution was subtracted
for baseline correction. Baseline corrected data were analyzed with Origin
7.0 software. For S. cerevisiae Gle1CTD•Nup42GBM, cell and syringe concentrations
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of 5 and 50 μM were used for Gle1CTD•Nup42GBM and IP6, respectively. For
human Gle1CTD•Nup42GBM, measurements were made at identical conditions to S.
cerevisiae Gle1CTD•Nup42GBM, as well as at cell and syringe concentrations of 200
μM and 2mM for Gle1CTD•Nup42GBM and IP6, respectively.
Electrophoretic mobility shift assay. The electrophoretic mobility of free or
DDX19-bound RNA was evaluated on native 1.4% (w/v) agarose gels using a 53-
nucleotide single-stranded RNA probe (5′-GUUUU UUUUU UUUUU UUUUU
UCUCG AUCCG UAGUG AUCUA CUGAG CAUCU CCC-3′). The RNA was
prepared by in vitro transcription using T7 polymerase and according to the
MEGAscript protocol (Ambion). The transcribed RNA was loaded on a 8%
denaturing polyacrylamide-urea gel (19:1 acryl:bisacryl ratio and 8.3 M urea). The
RNA band was cut, eluted, and extracted with phenol:chloroform, followed by
ethanol precipitation. The pellet was resuspended in 10 mM TRIS (pH 8.5) buffer
and the concentration was detected by measuring the absorbance at 260 nm. The
RNA-protein reactions were carried out in 20 mM TRIS (pH 8.0), 100 mM NaCl, 2
mM MgCl2, 1 mM DTT, 10% (v/v) glycerol, and 1 mM AMP-PNP. The recom-
binant proteins used in each assay were incubated in binding buffer containing
AMP-PNP and then mixed with 25 ng of RNA. The ﬁnal reaction volume was 10 μl
and the ﬁnal protein concentrations were 1 μM Gle1CTD•Nup42GBM, 2 μM
Nup214NTD, and 1 μM DDX19. After mixing, samples were incubated on ice for
20 min before being loaded onto a 1.4% (w/v) native agarose gel using 0.25× TRIS
borate EDTA (TBE) buffer. Electrophoresis was carried out at a constant voltage of
9 V/cm at room temperature in 0.25× TBE buffer for 40 min. The gel was stained
with SYBR gold (1:10,000 dilution in 0.25× TBE buffer) for 3 min and imaged.
Crystal structure docking. Searches using the structures of
Gle1CTD•Nup42GBM•DDX19ΔN53(AMP-PNP•Mg2+) or Gle1CTD•Nup42GBM were
performed in a previously reported cryo-electron tomography reconstruction of the
intact human NPC (EMD-3103) using the Chimera FitMap tool48,64. Searches in
unaccounted cytoplasmic density were performed in a map generated by removing
density in the composite structure of the symmetric core of the NPC2. Searches
were performed with 50,000 initial placements within 100 Å of the cytoplasmic
outer ring that were locally optimized and scored based on correlation to a 25 Å
simulated map of the structures.
Illustrations and ﬁgures. All structural ﬁgures and movies were ray traced in
PyMol (Schrödinger). Surface electrostatic potential plots were calculated using
Adaptive Poisson-Boltzmann Solver (APBS)65. Secondary structure predictions
were generated with the PSIPRED server66. Sequence alignments were generated
using MUSCLE and visualized with ALSCRIPT67,68.
Data availability. Atomic coordinates and related structure factors have been
deposited in the Protein Data Bank with accession codes 6B4E, 6B4F, 6B4G, 6B4H,
6B4I, 6B4J, and 6B4K for the structures of S. cerevisiae Gle1CTD•Nup42GBM, H.
sapiens Gle1CTD•Nup42GBM, C. thermophilum Gle1CTD•Nup42GBM, C. thermo-
philum Gle1CTD•Nup42GBM•IP6, H. sapiens Gle1CTD•Nup42GBM•DDX19ΔN53
(ADP), H. sapiens Gle1CTD•Nup42GBM•DDX19ΔN53(AMP•PNP), and H. sapiens
DDX19ΔN53(AMP•PNP), respectively. Other data are available from the corre-
sponding author upon reasonable request.
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